Cost-effectiveness of second-generation antipsychotics for the treatment of schizophrenia. [electronic resource]
Producer: 20140825Description: 310-9 p. digitalISSN:- 1524-4733
- Adult
- Antipsychotic Agents -- economics
- Benzodiazepines -- economics
- Clozapine -- economics
- Cost-Benefit Analysis
- Dibenzothiazepines -- economics
- Drug Therapy, Combination
- Female
- Humans
- Male
- Markov Chains
- Olanzapine
- Piperazines -- economics
- Quality-Adjusted Life Years
- Quetiapine Fumarate
- Risperidone -- economics
- Schizophrenia -- drug therapy
- Thiazoles -- economics
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.